This study investigates pancreatic cancer with liver metastases. It focuses on patients with pancreatic ductal adenocarcinoma who have resectable primary tumors and up to three liver metastases.
The purpose of this study is to evaluate the effects of a treatment plan that includes surgery and medication. It looks at how well the treatment works for patients with this type of cancer.
- Who can participate: Adults with pancreatic ductal adenocarcinoma and resectable primary tumors may be eligible. Participants must have up to three liver metastases and be fit for surgery.
- Study details: Participants will receive a combination of surgery and medication.